P. SULTAN Et Al. , "Efficacy and Safety of Intra-vitreal Bevacizumab (Avastin®) Using Pro Re Nata Regimen in Treatment of Macular Edema Due to Retinal Vein Occlusion," Retina-Vitreus , vol.24, no.4, pp.313-318, 2016
SULTAN, P. Et Al. 2016. Efficacy and Safety of Intra-vitreal Bevacizumab (Avastin®) Using Pro Re Nata Regimen in Treatment of Macular Edema Due to Retinal Vein Occlusion. Retina-Vitreus , vol.24, no.4 , 313-318.
SULTAN, P., ARVA ÇÖKEM, S., SARICI, A. M., UÇAR, D., & DİKKAYA, F., (2016). Efficacy and Safety of Intra-vitreal Bevacizumab (Avastin®) Using Pro Re Nata Regimen in Treatment of Macular Edema Due to Retinal Vein Occlusion. Retina-Vitreus , vol.24, no.4, 313-318.
SULTAN, Pınar Et Al. "Efficacy and Safety of Intra-vitreal Bevacizumab (Avastin®) Using Pro Re Nata Regimen in Treatment of Macular Edema Due to Retinal Vein Occlusion," Retina-Vitreus , vol.24, no.4, 313-318, 2016
SULTAN, Pınar Et Al. "Efficacy and Safety of Intra-vitreal Bevacizumab (Avastin®) Using Pro Re Nata Regimen in Treatment of Macular Edema Due to Retinal Vein Occlusion." Retina-Vitreus , vol.24, no.4, pp.313-318, 2016
SULTAN, P. Et Al. (2016) . "Efficacy and Safety of Intra-vitreal Bevacizumab (Avastin®) Using Pro Re Nata Regimen in Treatment of Macular Edema Due to Retinal Vein Occlusion." Retina-Vitreus , vol.24, no.4, pp.313-318.
@article{article, author={Pınar SULTAN Et Al. }, title={Efficacy and Safety of Intra-vitreal Bevacizumab (Avastin®) Using Pro Re Nata Regimen in Treatment of Macular Edema Due to Retinal Vein Occlusion}, journal={Retina-Vitreus}, year=2016, pages={313-318} }